watchman flx (Boston Scientific Corporation)
90
Structured Review
Boston Scientific Corporation
watchman flx
Watchman Flx, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/watchman+flx/watchman+flx/nct05560204-17-0-2
Average 90 stars, based on 1 article reviews
Watchman Flx, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/watchman+flx/watchman+flx/nct05560204-17-0-2
Average 90 stars, based on 1 article reviews
watchman flx - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet: A Randomized Controlled Study Article Snippet: Article Title: Definite Device-Related Thrombus on Cardiac Computed Tomography as a Fabric-Related Thrombus Mimic on Transesophageal Echocardiography Article Snippet: A patient after LAAC using Article Title: Cryoballoon-Based Left Atrial Appendage Isolation and Closure in Patients with Atrial Fibrillation-The LALALAND Pilot Study. Article Snippet: The utilized LAA-closure devices were Article Title: Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation Article Snippet: METHODS In this ongoing, prospective, international, randomized trial involving patients with atrial fibrillation who were suitable candidates for anticoagulation, we randomly assigned patients in a 1:1 ratio to receive either device-based left atrial appendage closure (device group) or non–vitamin K antagonist oral anticoagulant (NOAC) therapy (anticoagulation group).. The primary efficacy end point — a composite of death from cardiovascular causes, stroke, or systemic embolism — was tested for noninferiority (noninferiority margin, 4.8 percentage points) after 3 years of follow-up.. The primary safety end point, non–procedure-related bleeding, was tested for superiority. Article Title: Left Atrial Appendage Occlusion in the Era of Minimalist Approaches: Anesthesia and Imaging Considerations Article Snippet: Currently, the most widely used devices include the Article Title: Massive late device-related thrombus with watchman FLX left atrial appendage closure device two years after implantation: A case report Article Snippet: In this report, we describe an unusual case of a patient with a small DRT initially identified on transesophageal echocardiography (TEE) 6 weeks after implantation of a Article Title: Left Atrial Appendage Occlusion in the Era of Minimalist Approaches: Anesthesia and Imaging Considerations. Article Snippet: Currently, the most widely used devices include the |